November 03, 2008Major Study Of Zoloft And CBT For Kids' Anxiety Has Its Own IssuesLast week an interesting study of anxiety treatment in kids and teens came out in the New England Journal of Medicine and it's gotten quite a bit of press attention. The study involved using Zoloft, an SSRI, and cognitive behavioral therapy to treat anxiety disorders in teens and kids as young as seven and as old as 17. Look, I know how much some readers hate SSRIs and how strongly they react to any news about the drugs, pro or con, but for the moment put those kinds of concerns aside. My point in picking apart this study isn't to argue that no kid should ever be diagnosed with anxiety or that they shouldn't take meds of that therapy is useless or anything of the sort. My point is that this study isn't quite all that it's cracked up to be, although it does have its moments. In the study the authors assert that the findings have major public health implications, meaning the findings can be extrapolated to the entire population of kids and teens diagnosed with a range of anxiety disorders. If true, it would affect approximately 7.5 million to 15 million kids and teens in America (the authors claim that anxiety disorders affect 10 percent to 20 percent of Americans under 18). That's a whole lot of kids. The authors also claim that anxiety disorders in youth lead to anxiety and depression as the kids turn into adults--one of the usual arguments for giving kids psychiatric treatment. Certainly, the degree to which CBT was shown to be useful is valuable information as was the fact that CBT-only treatment outperformed Zoloft-only therapy by about 10 percent. But the fact that Zoloft had a fairly typical effect size of about 30 percent over placebo was hardly a ringing endorsement of meds-alone treatment, which is much the standard in America these days for kids (and adults). The study involved 488 kids and teens diagnosed with social phobia, generalized anxiety disorder and separation anxiety and lasted for three months (there will be a longer term version of this study published later). Patients given placebo improved--the authors' terminology--23.7 percent of the time; patients given Zoloft improved 54.9 percent of the time; patients given CBT improved 59.7 percent of the time (so psychotherapy beat an SSRI); and, patients given a combination of Zoloft and CBT improved 80.7 percent of the time. In other words, the SSRI plus psychotherapy approach had a 57 effect size over placebo and a 20 percent to 25 percent effect size over either meds or therapy alone. The result for Zoloft plus CBT is one of the most robust I have ever seen in any psychiatric study, so robust that it gives me doubts. My concern about this study and the way it's being portrayed in the media, however, involves a problem in the study design, which overall is actually quite good. But here's the deal: if you are going to go around claiming that Zoloft plus CBT is now indicated for anxiety disorder in kids and teens--and that's what the study authors claim--then you need a way to compare the Zoloft plus CBT arm of the study to a placebo plus CBT group of patients in order to allow for whatever placebo effect--likely 20 percent or more--was present in the Zoloft plus CBT group. There was no such group in the study. Instead, we got a placebo-only group, a Zoloft-only group, a CBT-only group and a CBT plus Zoloft group. It's a bit remarkable to me that if, as the authors note, they were trying to tease out of this study how powerful a therapy plus meds approach was that they didn't include a placebo plus therapy group. It would make comparisons and conclusions much easier and more powerful. What's more, my guesstimate is that such a group would've ended up with about a 65 percent to 70 percent "improvement" rate, leaving the Zoloft plus CBT group (at about an 80 percent improvement rate) with a 10 percent to 15 percent effect size. In the real world, that isn't much. As a result of this, I don't think the study's conclusions on meds plus therapy are nearly as conclusive as some commentators do. "The new study, paid for by the National Institute of Mental Health, is the largest examining treatment of childhood anxiety disorders, said co-author Dr. John March of Duke University. Dr. Thomas Insel, the institute's director, said the study provides strong evidence that combined treatment is 'the gold standard,' but that sertraline or therapy alone can be effective." Yes, but the question is how effective. Doug Bremner, a psychiatrist at Emory University, argues that the results are not remarkable at all: "So now let's turn to the "incredible" results of this week's study of sertraline (Zoloft) in kids. Although there was a difference in "responders" based on much improved on the CGI of 60% versus 24% for placebo, when you look at the actual data, the Pediatric Anxiety Scale, a 30 point scale, went from 18.8 at baseline to 9.8 in the zoloft group, and from 19.6 to 12.6 in the placebo group, a difference of 9%." While I'm no expert on this particular scale, it does strike me that the results of this study aren't nearly as far-reaching as some would like them to be, or as some fear they might be. Then, there's the whole tricky issue of giving SSRIs to kids as young as eight--fully 75 percent of the study participants are 13 or younger. While I'm not 100 percent opposed to giving SSRIs to kids, I'm like 90 percent against it, especially for minor cases of anxiety such as some kids in this study had (you're going to, as a parent, willingly give your kid Zoloft for social phobia or separation anxiety? Whatever). I don't think the fact that there were few side effects in any of the study's arms should give anyone too much peace--there were perhaps 200 kids on meds in the study (so it's hardly population based) and it's clear the docs did a commendable job of titrating the kids onto Zoloft (real world docs tend to be a lot more sloppy and I think that leads to all sorts of problems). I certainly wouldn't use the low side effects outcome of this study to project onto, say, 50,000 kids with anxiety disorders. And it's when you get into populations of that size that you begin to see the real problems with SSRIs, even if they are relatively few on a percentage basis. Nonetheless, I think the study authors did a commendable job of monitoring and reporting side effects--the paper is certainly the most aggressive on this point that I've seen in recent years in the use of SSRIs. While I know some of you will want to nitpick me over that assessment, please remember how studies like this used to address side effects issues in the past--hardly at all. So this new study represents an improvement on that front. For what it's worth to you all, CL Psych agrees with me on this point and there is no sterner judge of research methodology than that anonymous blogger. All the same, my jaw is simply on the floor over something else that underlies the study's social context. Twenty years ago, children were not medicated for anxiety disorders (can you imagine giving an MAOI or tricyclic to a child for any disorder?), except perhaps in rare instances, nor were they packed off to a psychiatrist if they exhibited signs of anxiety. And yet here we are today with psych researchers talking about implications for American kids as a whole and while I am pleased to see a solid emphasis on psychotherapy, I am very leery of the broader message getting out there that kids with anxiety should be on an SSRI and CBT. Because in the real world of our wonderful economy and broken health care system, the kids aren't going to end up getting psychotherapy unless their parents are fairly well off. Zoloft in generic form is quite cheap. CBT can easily run $120 or more a session. Guess which option insurance companies will go for? And after 20 years of our culture pushing SSRIs and other psych meds down the throats of adults with depression, anxiety and other disorders, can anyone point me to where this has improved things and what the argument would be for thinking it'll be any better for kids? As usual, perhaps I am pushing the envelope a bit hard by asking these questions and raising these issues, but someone has to do it. Posted by Philip Dawdy at November 3, 2008 12:05 AM
del.icio.us
Digg it
reddit
Comments
"then you need a way to compare the Zoloft plus CBT arm of the study to a placebo plus CBT group of patients in order to allow for whatever placebo effect--likely 20 percent or more--was present in the Zoloft plus CBT group. There was no such group in the study. Instead, we got a placebo-only group, a Zoloft-only group, a CBT-only group and a CBT plus Zoloft group." Before I'd buy Doug Bremner's argument, I want to know several things One other thing to consider is that here's no way to tell which kids will be "Zoloft responders" and which ones will not, or may even worsen. Other types of drugs, antihypertensives to anti-cholesterol meds, are subject to the same peril to some extent, but psych meds are particularly troublesome in this way (and with, say, Zocor, at least you can count on someone's cholesterol not actually getting higher as a result of the treatment). And this is independent of the fact that it's difficult to objectively assess whether someone's depression has genuinely abated using available metrics. What I take from this study is that it's a good idea to get kids who need help into therapy whenever possible. There's your starting point; whether or not to mix in an SSRI should be tabled for later. Nice assessment, in any event. The lack of a CBT plus placebo group is not merely a mild oversight, it's a crippling design flaw IMO. Posted by: bexter at November 2, 2008 10:26 PMI interviewed the primary researcher in this study about 2 years ago, when I saw it up up on the FDA site. In a 90 minute telephone conversation, he assured me the study was to "not have what happened to your daughter, happen to another child". When I called him on using Zoloft as a treatment in the study. I'll find the notes, back then I threatened to shut this study down due to the Zoloft use in children, CBT or not those parents were paid to enroll their kids to use a drug that sent mine through the roof, and I was not happy with it. This is why they contacted me to talk. They even wanted to talk to my daughter. Oh well, what do I know. Posted by: Stephany at November 2, 2008 10:32 PMBremner might want to check out Cl Pysch's blog re: Nemeroff, due to co -authouring 200 or so papers with him. Readers might want to check out Bremner's site, he specializes in PTSD. In the meantime, I will be contacting my source re: this study and post the interview on my blog. Posted by: Stephany at November 2, 2008 10:35 PMPS-Philip do you remember me telling you about this study?!!!!!!! Posted by: Stephany at November 2, 2008 10:39 PMMr. Bremner has some interesting findings such as "subjects with PTSD had a 5% increase in hippocampal volume and a 35% increase in memory function (Bremner, 2006)*." This hippocampal volume is also increased on London cab-drivers when they prepare themselves to the "The Knowledge" test. What really concerns me about this trial, to be honest, is the failure to provide more detail about concomitant medication and/or prior treatment. The study did not rule out children diagnosed with ADHD on "stable" doses of stimulants and, according to a table in the study, nearly 12% of the kids had ADHD. Over 2% of the kids had "tic disorder," according to that table, which can be a red flag for treatment with stimulants and/or neuroleptics and even antidepressants. They did exclude children who had not had "adequate responses" to two prior treatments of SSRIs, they claim in the text of the article, which means they could have been including children who did have "adequate responses" or else had just had one prior course of SSRIs. This throws in the distinct possibility that at least some of these events occurring in the trial might have been related to withdrawal rather than anxiety. Looking at the detailed adverse event chart available through a link on Clinical Psych's blog might make one think that. Whether or not that is the case the adverse events of kids on active treatment are qualitatively more serious than either of the "inactive" arms, including two incidents of homicidal ideation and a total of 21 serious adverse events out of 133 kids in the combo arm which gives me pause. As far as I'm concerned I'm afraid the failure to provide adequate detail on concomitant or prior treatment factors and how they related to adverse events nearly voids the whole study. I realize that this practice of ignoring concomitant (to say nothing of prior) treatment is very standard in academic research but that doesn't make it right. 75% of the kids in the trial were under 13 and the mean age was 10. Personally I think it's criminal to give children this age Zoloft. The 12 week window is of course the"honeymoon" period on antidepressants. This study is going to go out to 6 months and I suspect the results will be more favorable to therapy alone at that time. But after 6 months the kids on Zoloft will be well on their way to a diagnosis of "bipolar" and additional cocktails of medication. So yes, I am one of those who jump on studies like this and see red when I'm reading them, but I do think the science here, however "well reported" it appears to be is not the whole story. Posted by: Sara at November 3, 2008 06:23 AMWow!! The homicidal ideation had two occurrences among 133 subjects in the Zoloft alone category. So this is Frequent, according to the criteria for adverse reactions - up to one in one hundred is Frequent and this is one in 66. No wonder www.SSRIstories.com has hundreds of cases of children in prison. Also, Suicidal ideation on Zoloft combined with CBT had 12 compared to 2 on placebo. This is six times as many! I imagine the strain of undergoing therapy while on Zoloft is pretty darn high. On Zoloft alone there were 5 who had suicidal ideation and only 2 who had suicidal ideation on placebo. This is about the same ratio that pushed the FDA to place the Black Box warning on antidepressants & suicidality for those under 25. Also, Aggression was 2 for Zoloft alone and 9 for Combo but 0 for placebo. And "disinhibition" was 19 for combo & 3 for placebo and "defiant behavior" was 12 for Combo and 2 for Placebo - plus hostility was 7 for Combo and 2 for placebo, plus "Habits/Mannerisms/Rituals was 12 for Combo and 0 for Placebo. Also "Increased Motor Activity" was 21 for Combo and 5 for Placebo. The only message I get from this chart is to be really, really careful with Combo!! This sort of study reminds me of the problem with studies years ago that "found" that post menopausal women who took estrogen supplements were healthier than pm women who didn't take it. It turned out that the researchers had the causation wrong. Years later it turned out that women who took estrogen were generally more affluent and thus able to afford medical care, to have healthier diets, and to exercise and just in general to afford the kind of recreation and mental stimulation that keeps a person young. Women who just took estrogen and were poor generally had a higher incidence of stroke, cancer and heart attacks than poor women who didn't take it. What if these studies indicate that the experience of being in a study and being told that you are not bad for being anxious but "sick" is at least temporarily ameliorating the kids anxieties or if the kids, in unhappy families, simply are happy and relieved to be at the pshrinks getting relatively positive attention, or to get the attention they get from their parents or someone as they are observed in the study, or of course coming from poor families are happier and treated better while in the study because of the money the family is receiving? I wonder what results a control group of people whose only participation in the study was being paid would be. Of course I agree with your points too and wonder how drugging a kid will help him if he's going to go on to have anxiety disorder as an adult, and of course how the kid is going to be harmed by being told he has an anxiety disorder in the long run. As many of your readers know, at first when you are in emotional distress it's comforting to be told you have a medical disease but in the end it's dehumanizing, invalidating and harmful to many of us, though I know others seem to find such a world view life saving. And of course there's the problem of violence. Expect to see more studies showing that adolescents with anxiety disorders are more violent used as an argument for pushing these drugs when research really indicates that kids who take psych drugs are more violent and there's no real way to diagnose "anxiety disorders." Can these drugs be helpful in limiting situations in children, probably. Perhaps with real trauma surviving ptsd kids in the short run even combined with therapy to work through the trauma and teach coping skills, but indefinitely, I'm not sure any study indicates such a thing. And what about the sexual side effects? What are the emotional and psychosocial implications of chemically castrating teenagers? Posted by: Sally at November 3, 2008 07:11 AMRe-reading the article there was actually no change on the anxiety scale in any group except the CBT only group. I revised my own post on this. http://www.beforeyoutakethatpill.com/2008/10/sertraline-kids.html As for the other comments, those were previously addressed on my website under the post 'disclosure, seroxat, etc'. And the number of co authored articles is 8 (not 200). Posted by: Doug Bremner at November 3, 2008 09:23 AMI am curious as to the criteria for improvement from anxiety. "Positive outcomes..." Um, specific? I am curious also if narrowing the scope of a study like this to anxiety works the system to a more favorable outcome, closer to hypothesis. Posted by: Sophia at November 3, 2008 05:40 PMDoug, I thought I found the 200 co-authored articles stat on your site; sorry for the mis-information of facts on my part here. Though Google scholar is and easy reference for those interested in 'Nemeroff Bremner'. Zoloft, of course we know was the drug Chris Pittman was taking in 2001 when he killed his Grandparents, and it's the one drug that sent my then 13 year old into suicidal/homicidal rage/attempt, etc. My concern with the study when I spoke to one of the researchers in 2006 was that withdrawals, dosages etc were variables most parents had no idea of how to chart, or handle, or expect. They also changed the title of that study several times, as the years have passed. At any rate, I speak from a personal perspective, we all have different life events that influence research or passionate discussion in this forum, and for me, this is one of them. The researcher I spoke with in length also wanted to speak to my daughter about her Zoloft experience, yet unfortunately she was unable to due to becoming non-verbal. A decade later, I reside in a complex world with my daughter's care. Respectfully Stephany Posted by: Stephany at November 3, 2008 06:40 PMBremner Nemeroff google search for starters. Charles Nemeroff, of course was in recent news re: Emory, pharma money non-disclosure. Bremner is a collegue at Emory. Posted by: Stephany at November 3, 2008 06:55 PMI've visited Mr. Bremner's blog and found nothing. "However, to my knowledge it isn't known if this effect persists after discontinuation. What else? That it can cause prolonged sexual dysfunction after discontinuation? In my experience sexual function improves after discontinuation, although as I have said before I am always interested in hearing about new problems that people have with medications. Do you have that problem?" I've wrote you a post Mr. Bremner explaining PSSD, a condition I have already told you that is even on Wikipedia: I believe that suicide and violent behavior is already known. "Finally however there will be a group of people who are simply unable to stop whatever approach they take. Some others will be able to stop but will find problems persisting for months or years afterwards. It is important to recognize this latter possibility in order to avoid punishing yourself. Specialist help may make a difference for some people in these two groups, if only to provide possible antidotes to attenuate the problems of ongoing SSRIs such as loss of libido." Stephany, Using google scholar is not a good way to count publications because it magnifies whatever has been posted on the internet. Pubmed is also on the internet, free, and gives an exact count. Ana, I have responded to you repeatedly before on other web sites. As I have said before, I am not a spokesperson for paroxetine or SSRIs, but I am willing to answer your questions. First of all, I never said that SSRIs should be withdrawn in a matter of weeks. I taper over the course of two months, and if there are any issues I work with the patient to modify the withdrawal schedule. As to your being "appalled" that I was not aware of the syndrome of sexual dysfunction that persists permanently after discontinuation of SSRIs, I looked at the PSSD wikipedia entry you mentioned and the Bahrick et al 2008 article states Since this article only recently came out, and since the literature on the topic is not well developed, although I am not precluding that you, or others, may have had this problem, I think that it hardly warrants such a reaction that I had not heard of such cases, although as I said before I am always interested to hear about new side effects of drugs that were not previously acknowledged. Anything else? Posted by: Doug Bremner at November 4, 2008 10:02 AMMr. Bremner, Posted by: Ana at November 4, 2008 12:44 PM Errata: "evidences 8 months is nothing" Yes, thanks for the research info site, I read a lot, (more than google searches). Posted by: Stephany at November 4, 2008 09:50 PM"My problem is this: It is now nearly three months since I stopped taking the Zoloft. Once the "physical" signs of withdrawal began to diminish (e.g., I haven't needed to take anything to sleep for three weeks now; I no longer experience the "itching" or the "passing-out sensation followed by muscle spasms") -- now, however, I seem to be mired in one of the worst depressions of my life. I've put on somewhere between 10-15 pounds over the past two months. My energy is low; I feel like I'm slogging through water much of the time. Basically, I'm sure I have all the classic symptoms of major depression, including powerful feelings of anguish, rage, and hopelessness -- except, thanks to many years working with a wonderful therapist and my own insight into antidepressants, I also recognize the perhaps iatrogenic nature of all this and am trying to ride it out, not to take it too personally." This is part of a testimony I've saved on 07/29, 2005 but unfortunately I didn't put the link amd could not find it searching. It seems it's not online or it's from Socialaudit discussion board that is closed for the moment. I'm just putting it here because I cannot understand how can it be that these problems are not known by researchers and some psychiatrists. depression is bad. like, it's really REALLY not good Posted by: corbin at January 1, 2009 06:39 PMPost a comment
|
Patient Blogs. Sites.
The Trouble With Spikol
Icarus Project Blog John's Bipolar Stories Seroxat (Paxil) Sufferers Stand Up! Seroxat (Paxil) Secrets The Bipolar View Writhe Safely soulful sepulcher Electro Boy Spiritual Emergency Mental Nurse Deborah Gray Mental Mommy The Splintered Mind bipolar.and.me Nurse Ratched Psych Person Trick Cycling for Beginners depression introspection Salted Lithium Living With A Purple Dog Polar Trippin' Mercurial Scribe Bipolar Chicks Blogging Beyond Meds Off Label Jung At Heart Graphic Truth Joysoup Apesma's Lament Soapy Water Outlaw Psychiatry Empirical Insanity Patient Anonymous Beyond Blue Psych Survivor Postpartum Progress The Happiness Project Finding Optimism The Gimp Parade Midlife and Treachery Secret Life of a Manic-Depressive Psych Tech Going Through Hell
Doctor Blogs. Sites.
Clinical Psych
World of Psychology CorePsych The Last Psychiatrist Carlat Report Blog Intueri Emotional Well-Being Scientific Misconduct Aaron Beck Cognitive Therapy Today Treatment Online Shrink Rap David Healy Dr. Dork NHS Blog Doctor Dr. X's Free Associations Dr. Sanity Anxious Mind Everyone Needs Therapy Counselling Resource
Activists. News.
Charlottesville Prejudice Watch
The Icarus Project MindFreedom AHRP Blog SSRI Stories Healthy Skepticism Psych Rights Treatment Advocacy Center Peter Breggin Schizophrenia News eDrugSearch Blog Nuts R Us News Disapedia WSJ Health Blog
Social Networking. Forums.
Beyond Meds Social Network
Mood Garden Paxil Progress Crazy Boards Forums Psych Central Forums Icarus Project Forums DepressionTribe MySpace Bipolar Group Bipolar World Pendulum.org Bipolar Planet About.com Bipolar
Science. Big Pharma. Ethics.
PharmaLot
Pharma Gossip Science Blogs Mind Hacks GoozNews Integrity in Science Neurophilospohy bioethics.net Drug Wonks Pharma Marketing Blog Pharma's Cutting Edge On Pharma Health Care Renewal
Current Affairs
Buzz Machine
To The People Andrew Sullivan Michelle Malkin Daily Kos Reason's Hit&Run The Agitator Press Think Jim Romenesko Rough Type Gawker The Graphic Truth Tail Rank Huffington Post Instapundit Little Green Footballs Talking Points Memo MoJo Blog
Seattle Stuff
Smoking. Stuff.
|

